These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 27305068)
1. Spritam--a new formulation of levetiracetam for epilepsy. Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068 [No Abstract] [Full Text] [Related]
2. Brivaracetam (Briviact) for epilepsy. Med Lett Drugs Ther; 2016 Jul; 58(1499):95-6. PubMed ID: 27403785 [No Abstract] [Full Text] [Related]
3. The place of levetiracetam in the treatment of epilepsy. Leppik IE Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126 [No Abstract] [Full Text] [Related]
4. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Neyens LG; Alpherts WC; Aldenkamp AP Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):411-9. PubMed ID: 7624492 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience of marketed Levetiracetam in an epilepsy clinic-a one year follow up study. Betts T; Yarrow H; Greenhill L; Barrett M Seizure; 2003 Apr; 12(3):136-40. PubMed ID: 12651077 [TBL] [Abstract][Full Text] [Related]
7. Levetiracetam monotherapy during pregnancy: a case series. Long L Epilepsy Behav; 2003 Aug; 4(4):447-8. PubMed ID: 12899868 [TBL] [Abstract][Full Text] [Related]
8. A new antiepileptic drug. Shorvon SD; van Rijckevorsel K J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894 [No Abstract] [Full Text] [Related]
9. [The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children]. Aĭvazian SO; Shiriaev IuS Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):33-8. PubMed ID: 22500310 [TBL] [Abstract][Full Text] [Related]
10. [Epileptic encephalopathy associated with forced normalization after administration of levetiracetam]. Kikuchi T; Kato M; Takahashi N; Nakamura K; Hayasaka K No To Hattatsu; 2013 Sep; 45(5):375-8. PubMed ID: 24205693 [TBL] [Abstract][Full Text] [Related]
11. Levetiracetam as a possible cause of fulminant liver failure. Tan TC; de Boer BW; Mitchell A; Delriviere L; Adams LA; Jeffrey GP; Macquillan G Neurology; 2008 Aug; 71(9):685-6. PubMed ID: 18725594 [No Abstract] [Full Text] [Related]
12. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy. Obeid M; Pong AW Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy. Li S; Cao J; Xiao N; Cai F J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208 [TBL] [Abstract][Full Text] [Related]
14. Issues in the treatment of epilepsy. Leppik IE Epilepsia; 2001; 42 Suppl 4():1-6. PubMed ID: 11564117 [No Abstract] [Full Text] [Related]
15. The SKATE study: interim analysis. Olwen GO Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896 [TBL] [Abstract][Full Text] [Related]
16. Initial management of epilepsy. Ammar H; Malani A; Mughal S N Engl J Med; 2008 Dec; 359(23):2500; author reply 2500. PubMed ID: 19065751 [No Abstract] [Full Text] [Related]
17. A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy. Robins A; Patel M; Azim A J Am Geriatr Soc; 2012 Jan; 60(1):159-60. PubMed ID: 22239298 [No Abstract] [Full Text] [Related]
19. Obsessive-compulsive behavior induced by levetiracetam. Fujikawa M; Kishimoto Y; Kakisaka Y; Jin K; Kato K; Iwasaki M; Nakasato N J Child Neurol; 2015 Jun; 30(7):942-4. PubMed ID: 25008911 [TBL] [Abstract][Full Text] [Related]
20. Role of levetiracetam in the treatment of epilepsy. Brodie MJ; French JA Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]